Sangamo Therapeutics(SGMO) Stock Price Today

US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist

0.7213
-0.0190-2.57%

Close Apr 29 16:00 ET

0.7214
+0.0001+0.01%

Post 20:01 ET

162.08MMarket Cap-1.47P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Sangamo Therapeutics To Present At 28th Annual Meeting of the American Society of Gene & Cell Therapy May 13-17
BenzingaApr 28 16:33 ET
TD Cowen Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating
Moomoo NewsApr 12 01:31 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $10 Price Target
BenzingaApr 7 08:48 ET
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
BenzingaApr 4 05:20 ET
Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday
BenzingaApr 4 03:02 ET
Stocks to Watch: Pamt, CXApp, Sangamo Therapeutics
WSJApr 3 19:37 ET

Comments

Teddy123

Yesterday 13:45

Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

$Sangamo Therapeutics (SGMO.US)$
We are proud to be showcasing our latest pipeline advances at ASGCT, including three platform presentations, reflecting our mission to develop innovative neurology genomic medicines to treat debilitating neurological diseases,” said Sandy Macrae, Chief Executive Officer of Sangamo Therapeutics. “We are particularly excited to...